BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25392796)

  • 1. Temporal trend, clinicopathologic and sociodemographic characterization of age at diagnosis of breast cancer among US women diagnosed from 1990 to 2009.
    Escarela G; Pérez-Ruiz LC; Núñez-Antonio G
    Springerplus; 2014; 3():626. PubMed ID: 25392796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Cause-Specific Mortality After Surgery for Women With Breast Cancer: A 20-Year Follow-Up Study From Surveillance, Epidemiology, and End Results Cancer Registries.
    Escarela G; Jiménez-Balandra A; Núñez-Antonio G; Gordillo-Moscoso A
    Breast Cancer (Auckl); 2017; 11():1178223417711429. PubMed ID: 28615951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Chu KC; Chang S; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing national mastectomy rates for the treatment of early stage breast cancer.
    Mahmood U; Hanlon AL; Koshy M; Buras R; Chumsri S; Tkaczuk KH; Cheston SB; Regine WF; Feigenberg SJ
    Ann Surg Oncol; 2013 May; 20(5):1436-43. PubMed ID: 23135312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
    Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment.
    Swanson GM; Lin CS
    J Natl Cancer Inst Monogr; 1994; (16):69-77. PubMed ID: 7999472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.
    Mattes MD; Bhatia JK; Metzger D; Ashamalla H; Katsoulakis E
    J Breast Cancer; 2015 Jun; 18(2):143-8. PubMed ID: 26155290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and Racial/Ethnic Differences of Colorectal Cancer Among Adolescents and Young Adults.
    Holowatyj AN; Lewis MA; Pannier ST; Kirchhoff AC; Hardikar S; Figueiredo JC; Huang LC; Shibata D; Schmit SL; Ulrich CM
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00059. PubMed ID: 31259751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status.
    Park JH; Anderson WF; Gail MH
    J Clin Oncol; 2015 Sep; 33(26):2870-6. PubMed ID: 26195709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.
    Anderson WF; Chu KC; Chatterjee N; Brawley O; Brinton LA
    J Clin Oncol; 2001 Jan; 19(1):18-27. PubMed ID: 11134191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Hispanic race/ethnicity and poverty in breast cancer survival.
    Delgado DJ; Lin WY; Coffey M
    P R Health Sci J; 1995 Jun; 14(2):103-16. PubMed ID: 7617830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.
    Johnson RH; Chien FL; Bleyer A
    JAMA; 2013 Feb; 309(8):800-5. PubMed ID: 23443443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Pfeiffer RM; Dores GM; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1899-905. PubMed ID: 17035397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.
    Rosenberg J; Chia YL; Plevritis S
    Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined.
    Polednak AP
    Ann Surg; 2003 Feb; 237(2):163-7. PubMed ID: 12560772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
    Wei JL; Zhang JX; Fu DY
    World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography use, breast cancer stage at diagnosis, and survival among older women.
    McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
    J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.